Changeflow GovPing Healthcare & Life Sciences USPTO Patent US12583820B2: Antivirals against c...
Routine Notice Added Final

USPTO Patent US12583820B2: Antivirals against coronavirus

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has granted patent US12583820B2 to Kansas State University Research Foundation for broad spectrum antivirals against coronaviruses. The patent covers specific chemical compounds designed to inhibit viral replication.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12583820B2, assigned to Kansas State University Research Foundation. This patent covers novel compounds exhibiting antiviral activity against viruses, particularly coronaviruses, and includes specific chemical formulas and classifications related to organic chemistry (C07D).

This patent grant represents a new intellectual property asset for Kansas State University Research Foundation. While patents do not impose direct regulatory obligations on other entities, they can influence market exclusivity and licensing opportunities for pharmaceutical and drug manufacturers developing antiviral therapies. Compliance officers should note this as a development in the intellectual property landscape relevant to coronavirus treatments.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Broad spectrum antivirals against coronavirus

Grant US12583820B2 Kind: B2 Mar 24, 2026

Assignee

Kansas State University Research Foundation

Inventors

Kyeong-Ok Chang, Yunjeong Kim, William C. Groutas, Stanley Perlman

Abstract

Compounds exhibiting antiviral activity and/or inhibition of viral replication against viruses, particularly those belonging to the picornavirus-like supercluster, including coronavirus having a formula: (I) where X comprises a cyclic moiety, R2 is a branched or unbranched alkyl, cycloalkyl, aryl, arylalkyl, alkenyl, alkynyl, amino acid side chain, bicyclic or tricyclic side chain, combinations, and substituted forms thereof, and Z is selected from the group consisting of C1-C6 hydroxyalkyl, aldehydes, alpha-ketoamides, and bisulfite salts, and in particular —CH2OH, —CHO, —CH(0H)S03−Na+, and -[0(C=0)Rw]S03−Na+.

CPC Classifications

C07D 207/26

Filing Date

2021-03-30

Application No.

17907745

Claims

12

View original document →

Named provisions

Abstract Claims

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12583820B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Antiviral Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Intellectual Property Public Health

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!